Drug Discovery Technologies - Global Market Outlook (2016-2022)

September 2016 | 134 pages | ID: D68756FE546EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Drug Discovery Technologies market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Rise in new diseases and growing demand for therapeutics in various diseases are the factors driving the market growth. Stringent regulations and high initial cost associated with drug discovery are the factors hampering the market. Discovering drugs for diseases like Parkinson disease, cancer, nervous disorders is the opportunity for the market growth.

Some of the key players in the market include Bayer Healthcare AG, Roche Holding AG, Boehringer Ingelheim GmbH, Illumina Inc., Millennium Pharmaceuticals, Inc., Abbott Laboratories, Beckman Coulter Inc., Aviva Biosciences Corp., Bio-Rad Laboratories, Inc., Novartis AG, Charles River Laboratories International, Inc., Evotec AG, Merck & Co., Inc., Viva Biotech Ltd, Sri Biosciences, GE Healthcare Ltd., Qiagen N.V. and Quantum Pharmaceuticals.

Technologies Covered:

• DNA & Protein Microarrays
• High Throughput Screening
• Genomics
• Biochips
• Proteomic Technologies
• Microfluidics
• Metabolomics
• Pharmacogenomics
• Gel Electrophoresis
• Bioanalytical Instruments
• Chromatography
• Bioinformatics
• QPCR
• Combinatorial Chemistry
• Mass Spectrometry
• Nanotechnology
• RNAi
• Nucleic Acid Isolation
• Protein
• Epigenetics
• Cell Based Assays
• Laboratory Information Management Systems

Applications Covered:

• Parkinson’s disease
• Cancer
• Central Nervous System Disorders
• Cardiovascular Diseases
• Other Applications

End Users Covered:

• Biopharmaceutical Companies
• Research Institutes
• Biotech Companies
• Pharmaceutical Companies

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY TECHNOLOGY

5.1 Introduction
5.2 DNA & Protein Microarrays
5.3 High Throughput Screening
5.4 Genomics
5.5 Biochips
5.6 Proteomic Technologies
5.7 Microfluidics
5.8 Metabolomics
5.9 Pharmacogenomics
5.10 Gel Electrophoresis
5.11 Bioanalytical Instruments
5.12 Chromatography
5.13 Bioinformatics
5.14 QPCR
5.15 Combinatorial Chemistry
5.16 Mass Spectrometry
5.17 Nanotechnology
5.18 RNAi
5.19 Nucleic Acid Isolation
5.20 Protein
5.21 Epigenetics
5.22 Cell Based Assays
5.23 Laboratory Information Management Systems

6 GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY APPLICATION

6.1 Introduction
6.2 Parkinson’s disease
6.3 Cancer
6.4 Central Nervous System Disorders
6.5 Cardiovascular Diseases
6.6 Other Applications

7 GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY END USER

7.1 Introduction
7.2 Biopharmaceutical Companies
7.3 Research Institutes
7.4 Biotech Companies
7.5 Pharmaceutical Companies

8 GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY GEOGRAPHY

8.1 North America
  8.1.1 US
  8.1.2 Canada
  8.1.3 Mexico
8.2 Europe
  8.2.1 Germany
  8.2.2 France
  8.2.3 Italy
  8.2.4 UK
  8.2.5 Spain
  8.2.6 Rest of Europe
8.3 Asia Pacific
  8.3.1 Japan
  8.3.2 China
  8.3.3 India
  8.3.4 Australia
  8.3.5 New Zealand
  8.3.6 Rest of Asia Pacific
8.4 Rest of the World
  8.4.1 Middle East
  8.4.2 Brazil
  8.4.3 Argentina
  8.4.4 South Africa
  8.4.5 Egypt

9 KEY DEVELOPMENTS

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 COMPANY PROFILING

10.1 Bayer Healthcare AG
10.2 Roche Holding AG
10.3 Boehringer Ingelheim GmbH
10.4 Illumina Inc.
10.5 Millennium Pharmaceuticals, Inc.
10.6 Abbott Laboratories
10.7 Beckman Coulter Inc.
10.8 Aviva Biosciences Corp.
10.9 Bio-Rad Laboratories, Inc.
10.10 Novartis AG
10.11 Charles River Laboratories International, Inc.
10.12 Evotec AG
10.13 Merck & Co., Inc.
10.14 Viva Biotech Ltd
10.15 Sri Biosciences
10.16 GE Healthcare Ltd.
10.17 Qiagen N.V.
10.18 Quantum Pharmaceuticals

List Of Tables

LIST OF TABLES

1 Global Drug Discovery Technologies Market Outlook, By Region (2013-2022) ($MN)
2 Global Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
3 Global Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
4 Global Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
5 Global Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
6 Global Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
7 Global Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
8 Global Drug Discovery Technologies Market Outlook, By Microfluidics (2013-2022) ($MN)
9 Global Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
10 Global Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
11 Global Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
12 Global Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
13 Global Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
14 Global Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
15 Global Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
16 Global Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
17 Global Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
18 Global Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
19 Global Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
20 Global Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
21 Global Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
22 Global Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
23 Global Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
24 Global Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
25 Global Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
26 Global Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
27 Global Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
28 Global Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
29 Global Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
30 Global Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
31 Global Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
32 Global Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
33 Global Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
34 Global Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
35 Global Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
36 North America Drug Discovery Technologies Market Outlook, By Country (2013-2022) ($MN)
37 North America Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
38 North America Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
39 North America Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
40 North America Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
41 North America Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
42 North America Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
43 North America Drug Discovery Technologies Market Outlook, By Microfluidics (2013-2022) ($MN)
44 North America Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
45 North America Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
46 North America Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
47 North America Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
48 North America Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
49 North America Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
50 North America Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
51 North America Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
52 North America Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
53 North America Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
54 North America Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
55 North America Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
56 North America Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
57 North America Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
58 North America Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
59 North America Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
60 North America Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
61 North America Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
62 North America Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
63 North America Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
64 North America Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
65 North America Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
66 North America Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
67 North America Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
68 North America Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
69 North America Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
70 North America Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
71 Europe Drug Discovery Technologies Market Outlook, By Country (2013-2022) ($MN)
72 Europe Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
73 Europe Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
74 Europe Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
75 Europe Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
76 Europe Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
77 Europe Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
78 Europe Drug Discovery Technologies Market Outlook, By Microfluidics (2013-2022) ($MN)
79 Europe Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
80 Europe Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
81 Europe Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
82 Europe Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
83 Europe Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
84 Europe Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
85 Europe Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
86 Europe Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
87 Europe Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
88 Europe Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
89 Europe Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
90 Europe Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
91 Europe Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
92 Europe Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
93 Europe Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
94 Europe Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
95 Europe Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
96 Europe Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
97 Europe Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
98 Europe Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
99 Europe Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
100 Europe Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
101 Europe Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
102 Europe Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
103 Europe Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
104 Europe Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
105 Europe Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
106 Asia Pacific Drug Discovery Technologies Market Outlook, By Country (2013-2022) ($MN)
107 Asia Pacific Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
108 Asia Pacific Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
109 Asia Pacific Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
110 Asia Pacific Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
111 Asia Pacific Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
112 Asia Pacific Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
113 Asia Pacific Drug Discovery Technologies Market Outlook, By Microfluidics (2013-2022) ($MN)
114 Asia Pacific Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
115 Asia Pacific Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
116 Asia Pacific Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
117 Asia Pacific Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
118 Asia Pacific Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
119 Asia Pacific Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
120 Asia Pacific Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
121 Asia Pacific Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
122 Asia Pacific Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
123 Asia Pacific Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
124 Asia Pacific Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
125 Asia Pacific Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
126 Asia Pacific Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
127 Asia Pacific Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
128 Asia Pacific Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
129 Asia Pacific Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
130 Asia Pacific Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
131 Asia Pacific Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
132 Asia Pacific Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
133 Asia Pacific Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
134 Asia Pacific Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
135 Asia Pacific Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
136 Asia Pacific Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
137 Asia Pacific Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
138 Asia Pacific Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
139 Asia Pacific Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
140 Asia Pacific Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
141 RoW Drug Discovery Technologies Market Outlook, By Country (2013-2022) ($MN)
142 RoW Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
143 RoW Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
144 RoW Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
145 RoW Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
146 RoW Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
147 RoW Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
148 RoW Drug Discovery Technologies Market Outlook, By Microfluidics (2013-2022) ($MN)
149 RoW Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
150 RoW Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
151 RoW Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
152 RoW Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
153 RoW Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
154 RoW Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
155 RoW Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
156 RoW Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
157 RoW Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
158 RoW Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
159 RoW Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
160 RoW Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
161 RoW Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
162 RoW Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
163 RoW Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
164 RoW Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
165 RoW Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
166 RoW Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
167 RoW Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
168 RoW Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
169 RoW Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
170 RoW Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
171 RoW Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
172 RoW Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
173 RoW Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
174 RoW Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
175 RoW Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)